We investigated the incidence and clinical features of priapism in Japan, using a national administrative claims database, the Diagnosis Procedure Combination database. Priapism patients were identified using the International Classification of Diseases and Related Health Problems, 10th Revision code, N483 (priapism). Verified patient characteristics included age, comorbidities and management of priapism. Among 6.93 million inpatients, 46 patients with priapism were identified. Four had two admissions each for repeated events. The median age was 41.5 years (range, 11-89 years). A total of 21 patients had comorbidities; 3 had haematological malignancies, 4 had haemodialysis, 1 had a renal transplant, 2 had neurological problems, 4 had non-haematological malignancies, 3 had trauma and 6 had psychoses (2 cases had two comorbidities). All patients with non-haematological malignancies were over the age of 70 years, indicating that close attention is required to search for associated malignancies in elderly patients. The medical treatments included 6 vascular embolizations, 11 Winter method surgeries and 18 other operations. The incidence was estimated to be 0.13 (95% confidence interval, 0.097-0.17) per 100 000 person-years. This incidence was lower than that reported in other parts of the world.
Introduction
Priapism is a prolonged and uncontrollable penile erection developing without sexual stimulation or excitement. 1 Conventionally, priapism is classified into two types by its presentation; ischaemic priapism (veno-occlusive or low-flow type) and non-ischaemic priapism (arterial or high-flow type). Ischaemic priapism is characterized by the obstruction of penile venous outflow, which renders the penis ischaemic. It requires emergency treatment to regain the cavernous flow to avoid irreversible fibrosis and necrosis of the penis over a period of 12-48 h. 2 From a clinical viewpoint, 4 h persistence is recognized as a criterion for emergency treatment. 1 The causes of ischaemic priapism include leukaemia, sickle cell disease and intracavernous injection of vasoactive agents. Non-ischaemic priapism features an increase in arterial inflow through the corpora cavernosa. Usually the penis remains oxygenated sufficiently and neither fully rigid nor painful. Peripheral trauma and injury to the internal pudendal artery are common causes. 1, 3 Because of its rarity, the epidemiology of priapism has been less reported despite its clinical importance. To our knowledge, only three papers have reported the incidence of priapism so far. [4] [5] [6] The present study evaluated the incidence of priapism and estimated its aetiology in Japan, using the Diagnosis Procedure Combination (DPC) database, a nationwide administrative database.
Materials and methods
The DPC database The DPC database is designed as an inpatient care database in Japan that includes administrative claims and discharge data. Because of the anonymous nature of the data collection, the requirement for informed consent was waived. Study approval was obtained from the Institutional Review Board in the University of Occupational and Environmental Health.
Study samples
All patients with priapism in 2006, 2007 and 2008 were identified by an electronic search of the records for the ICD-10 code, N483 (priapism). We extracted data on patient age, comorbidities, surgical procedures, records of medical resources used and the length of stay.
To assess priapism aetiology, we also identified those comorbidities that are well known to be associated with priapism, with reference to CampbellWalsh Urology, 9th edition, namely haematological dyscrasias, neurological conditions, non-haematological malignant neoplasms, trauma, pharmacological exposures, idiopathic and unknown. 10 
Estimation of incidence
The incidence of priapism was estimated using a person-year method. We determined the cohort population by multiplying the corresponding male population by the DPC coverage rate. We calculated the 95% confidence intervals (CIs) using PASW version 18.0 (SPSS Inc., Chicago, IL, USA).
Results
Among 6.93 million inpatients in the study population, we identified 46 patients diagnosed with priapism. Four had two admissions each for duplicated events of priapism ( Table 1 ). The median age was 41.5 years (range, 11-89 years), and the median hospital stay was 8 days (range, 2-90 days). In all, 33 (72%) patients underwent medical intervention. The interventions included 6 (13%) arterial embolizations, 11 (24%) Winter method surgeries and 18 (39%) other surgical procedures. Four patients each received two interventions. All three patients with haematological malignancies received chemotherapy. The median duration between admission and the first intervention was 1 day (range, 1-12 days). Table 2 shows details of the comorbidities in 21 (46%) patients. The comorbidities comprised three (6.5%) with haematological malignancies, four (8.7%) with kidney disease requiring haemodialysis, one with post renal transplantation (2.2%), two (4.3%) with neurological problems, four (8.7%) with non-haematological malignancies, three (6.5%) with trauma and six (13%) with psychoses. Two cases each had two comorbidities. All four non-haematological malignancies were urological (three bladder cancers and one prostate cancer), and all these patients were aged over 70 years. Table 3 shows the calculation of the incidence of priapism. Data on the male population in Japan were obtained from the Population Census Data. The cohort population comprised 35 580 000 personyears. The incidence of priapism was calculated as 0.13 (95% CI, 0.097-0.17) per 100 000 person-years.
Discussion
The previously reported incidence of priapism varied widely because of differences in the study population and periods: 0.34-0.52 per 100 000 person-years in Finland (207 inpatients during 1975-1990), 6 0.84 in Western Australia (63 emergency room visitors during 1985-2000) 4 and 0.5 in The Netherlands (41 inpatients in 1995). 5 In Asian countries, sporadic case reports and their reviews have been published. [11] [12] [13] [14] Furukawa et al. 11 collected Incidence of priapism in Japan T Sugihara et al 129 cases, which were all reported cases in 1930-1963 in Japan. The present study was based on in-hospital data, and the incidence of priapism was estimated to be B0.13 per 100 000 person-years in Japan, which was lower than that in other parts of the world, as described above. [4] [5] [6] Because outpatient cases were not censored in the present study, the total incidence of priapism is likely to be higher. For instance, the Dutch study mentioned above made a rough estimation of the incidence in the whole population as 1.5 (95% CI, 0.2-2.8), using general practitioner registry data during 1995-1999, 5 and it implied that a threefold disparity could occur between an in-hospital database study and a general population-based study.
The reasons for the low incidence in Japan remain unclear. Racial differences may be a contributor, for example, there were no patients with sickle cell disease among the Japanese population, which is a well-known risk factor for priapism. 15, 16 Priapism can be caused by some types of treatment for erectile dysfunction (ED), such as intracavernous injection. We believe that the conservative attitudes of the Japanese population to ED treatments are one of the reasons for the low rate of priapism. Namiki et al. 17 investigated 447 Japanese and 427 American males treated for prostate cancer and found that, even though the overall sexual activity of the Japanese was less than that of the Americans, the Japanese were less likely to have concerns about their sexual behaviour. 18 Another study revealed that people in East Asia, including Japan, were less eager to seek help from medical doctors for sexual problems compared with those in European countries (6.5 vs 17.4-20.4%). 
Incidence of priapism in Japan T Sugihara et al A Japanese study showed that only 4.8% of male patients with ED consulted a medical doctor. 20 After the introduction of intracavernous injection therapy for ED in the 1980s, an increase in priapism was recognized in Finnish and Dutch studies. [4] [5] [6] 21, 22 The Dutch study found that the incidence of iatrogenic priapism as a result of treatment for ED was approximately equal to that from other causes. Today, self-injection kits are available officially in more than 80 countries including The Netherlands and Finland. On the other hand, no self-injection kit has been approved by the Japanese authority, the Ministry of Health, Labour and Welfare. Hence, Japanese males cannot obtain the kits from medical doctors or pharmacies, but they can import them at their own risk if they desire self-injection.
The present study showed that 21 of 46 patients (46%) had comorbidities, which are associated with priapism. Although some patients were transferred to DPC hospitals after receiving intracavernous injection therapy for priapism in other medical institutions, we could not obtain information on these injections from the database. Other reports evaluating previously documented cases also showed that as many as half of the cases of priapism are idiopathic or have no discernible cause. 23, 24 The documented causes come from case reports. For example, haemodialysis is recognized as a comprehensive risk factor, which includes erythropoietin use and heparin administration. 10, 25, 26 It is noteworthy that four of five patients over the age of 70 years had urological malignancies. This suggests that these types of malignancies should be carefully investigated especially in aged priapism patients. Chan et al. 27 reviewed 52 cases of penile metastasis, and 14 (27%) presented with priapism, including 2 lung malignancy cases and 12 urological malignancy ones. Therefore, non-urological malignancy also can lead to priapism.
There are several limitations in the present study. First, the strict cause-effect relationship could not be confirmed precisely through the DPC database. Second, an administrative claims database could lead to underestimation of comorbidities or complications. Third, several clinical parameters could not be obtained, such as laboratory and physiological data, ischaemic or non-ischaemic type, intracavernous administration of vasoactive agents, duration of priapism presentation, alcohol or cocaine use, subsequent ED and so on.
Conclusions
The incidence of priapism found in Japan, 0.13 per 100 000 person-years, is lower than that reported in other parts of the world. About half the patients have causal comorbidities and close attention is required regarding the possibility of associated malignancies, especially in aged patients.
